Career Possibilities Panel & Speed Networking - Research & Development, Discovery

In the world of business, careers are no longer linear or predictable. What was once a clearly sign-posted path as you progressed through milestones, a career road map is now circuitous presenting new challenges and opportunities at every bend. Life-long careers in one sector or one company are becoming a rarity as new technologies and shifting social norms disrupt traditional careers. Both employers and employees are seeking more diversity of experience, lifestyle flexibility and alternative paths.

This panel is designed to help you think about your career path and the different options that are open to you. The panel will have an informational interview type feel with panelists sharing their career paths, a look at what their job entails, transferrable skills for those looking to make a change, tips for uncovering opportunities, advice for others, and how to make brave leaps. This panel will be moderated by Lesley Chan, Senior Director of Process Sciences and Innovations at bluebird bio. 

Panelists Include: 

  • Antara Banerjee- Senior Director, Head Cell Engager Therapies, Takeda
  • Celine Han- Principal Scientist, Translational Bioinformatics, Bristol Myers Squibb
  • Karen Perez de Arce- Principal Scientist I, Novartis
  • Jyothsna Viswesvaraiah- Director, Drug Creation, Seismic Therapeutic


Date and Time:  
April 26, 2023
6:00-7:30 PM EST

4 mins: Welcome
60 mins: Panel discussion
12 mins: Small group speed networking
2 mins: Learnings
12 mins: Small group speed networking



Download Flyer Here

Register Here


Thanks to Our Series Sponsor!



Antara Banerjee- Antara Banerjee received her Ph.D. in Pharmaceutical Sciences from the University of Maryland focusing on structure-function relationship of bile acid drug transporters and their role in cholesterol metabolism.  She did her postdoctoral training in Immunology at DNAX/Merck focusing on innate, adaptive immune mechanisms in infectious diseases and autoimmune indications. Currently as Senior Director and Head of Cell Engager Pillar, Oncology Drug Discovery Unit at Takeda, Antara is responsible for shaping the strategy and roadmap for Cell Engagers as part of the broader Oncology pipeline. Read More Here

Celine Han- Celine Han is a computational biologist and principal scientist in Translational Bioinformatics at Bristol Myers Squibb (BMS). Her focus of research is to advance oncology clinical trial programs and to influence development strategies by applying cutting-edge bioinformatic analyses on clinical trials and real-world data. Her work involves driving complex collaborations and communications with various partners for biomarker discovery and patient stratification. Read More Here.

Karen Perez de Arce- Karen is Principal Scientist I at Novartis Neuroscience department, where she led the efforts to establish cell-based assays for phenotypic characterization to support the drug discovery projects. Prior to NIBR, she joined the Stanley Center for Psychiatric diseases at Broad Institute of MIT and Harvard as Scientist after finishing her Posdoctoral training at Yale University and Tufts. Later, she transitioned from the Broad Institute to an early-stage Genomic Startup where she worked as Target Identification and Validation Scientist II. Karen received her Master degree in Biochemistry and a PhD in Cellular and Molecular Biology from Pontificia Universidad Catolica de Chile. Along with her career in research she did volunteering in organizations such as WEST, Seeding labs and SACNAS.

Jyothsna Visweswaraiah- Dr. Jyothsna Visweswaraiah is a scientist with drug development experience in small biotech and a track record of advancing new therapies into the clinic. She currently heads the Antibody Discovery group under the Drug Creation department at Seismic Therapeutic. Previously, she was head of the antibody discovery and engineering efforts at a Flagship Pioneering new co,  developing a modular, multi-specific biologics platform to address the complexities of biology. Prior to this, Jyothsna was at Pandion Therapeutics where she developed novel therapeutics designed to address the unmet needs of patients living with autoimmune diseases. Jyothsna has trained at Harvard Medical School and the National Institutes of Health. She has been an advocate for women in science and workplace inclusiveness. She mentors students interested in STEM careers and early career women scientists. Jyothsna also volunteers with The Antibody Society as a part of the communications and membership committee.


Check out our other events in this series: 

2/16/2023: Career Possibilities & Speed Networking: Communications
6/15/2023: Career Possibilities & Speed Networking: Clinical Development
8/24/2023: Career Possibilities & Speed Networking: Scientific & Medical Education